Method of preventing or reducing adverse reactions to...

Details Method of preventing or reducing adverse reactions to... Method of preventing or reducing adverse reactions to...

A - Human Necessities

61

K

167/205, 167/233

A61K 31/557 (2006.01) A61K 31/00 (2006.01) A61K 31/19 (2006.01) A61K 31/34 (2006.01) A61K 31/41 (2006.01)

Patent

CA 1336953

A method is provided for preventing, reducing or reversing adverse reactions, such as pulmonary hypertension produced when protamine interacts with heparin, by administering a thromboxane A2 receptor antagonist.

596348

Affiliated with

Also associated with

Rating

Method of preventing or reducing adverse reactions to... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of preventing or reducing adverse reactions to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preventing or reducing adverse reactions to... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1239053